Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Capital Reinvestment Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥446.51 Million) in capital expenditures (CN¥84.38 Million). See Shijiazhuang Yiling Pharmaceutical Co Lt net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shijiazhuang Yiling Pharmaceutical Co Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Shijiazhuang Yiling Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 17 annual periods. Check Shijiazhuang Yiling Pharmaceutical Co Lt (002603) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. For live market cap and broader valuation context, see market value of Shijiazhuang Yiling Pharmaceutical Co Lt.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥1.78 Billion | CN¥245.62 Million | ▼ -70.9% |
| 2024 | 0.48x | CN¥611.01 Million | CN¥290.39 Million | ▼ -76.2% |
| 2023 | 2.00x | CN¥155.46 Million | CN¥310.83 Million | ▲ +3159.0% |
| 2022 | 0.06x | CN¥3.49 Billion | CN¥213.98 Million | ▼ -95.2% |
| 2021 | 1.27x | CN¥528.69 Million | CN¥673.56 Million | ▲ +76.5% |
| 2020 | 0.72x | CN¥1.59 Billion | CN¥1.14 Billion | ▼ -89.1% |
| 2019 | 6.59x | CN¥68.93 Million | CN¥454.43 Million | ▲ +154.8% |
| 2018 | 2.59x | CN¥72.37 Million | CN¥187.23 Million | ▲ +64.5% |
| 2017 | 1.57x | CN¥114.65 Million | CN¥180.35 Million | ▲ +170.5% |
| 2016 | 0.58x | CN¥641.45 Million | CN¥373.03 Million | ▼ -84.0% |
| 2015 | 3.63x | CN¥131.88 Million | CN¥478.43 Million | ▼ -14.7% |
| 2014 | 4.25x | CN¥105.90 Million | CN¥450.19 Million | ▼ -42.6% |
| 2013 | 7.41x | CN¥55.32 Million | CN¥409.83 Million | ▲ +75.0% |
| 2012 | 4.23x | CN¥70.13 Million | CN¥296.89 Million | ▲ +345.2% |
| 2010 | 0.95x | CN¥299.72 Million | CN¥285.02 Million | ▲ +43.7% |
| 2009 | 0.66x | CN¥318.21 Million | CN¥210.57 Million | ▲ +8.4% |
| 2008 | 0.61x | CN¥210.18 Million | CN¥128.27 Million | — |